[Active monitoring of cefotetan use in surgery].
The authors studied efficacy and safety of cefotetan in 25 surgical patients, suffering from clinically and microbiologically tested infections. The average daily dose of the drug was 4 g in half of the cases and 6 g in the others. The average period of treatment was 8 days approximately. A clinically and microbiologically positive result was recorded in 88% of cases, while local and general safety was good in 92% of cases. Therefore, cefotetan confirmed to be an effective and reliable drug in general surgery.